Novavax
NVAX
153 hedge funds and large institutions have $889M invested in Novavax in 2014 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 54 increasing their positions, 46 reducing their positions, and 19 closing their positions.
68% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 19
43% more capital invested
Capital invested by funds: $623M → $889M (+$266M)
17% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 46
7% more funds holding
Funds holding: 143 → 153 (+10)
74% less call options, than puts
Call options by funds: $2.17M | Put options by funds: $8.32M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$5.14M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$4.95M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$4.54M |
| 4 |
Millennium Management
New York
|
+$4.18M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$4.12M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$14.4M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$9.54M |
| 3 |
First Eagle Investment Management
New York
|
-$2.08M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.83M |
| 5 |
State Street
Boston,
Massachusetts
|
-$1.75M |
NVAX Hedge Fund Activity: Q4 2014 in Review
153 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q4 2014, worth a combined $889M — up 43% from $623M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new NVAX positions and 19 closed out — a net gain of 13 holders — while 54 added to existing stakes and 46 trimmed.
The largest buyer was Invesco, adding an estimated $5.14M. The largest seller was Camber Capital Management, cutting an estimated $14.4M.
- 153 institutional investors held Novavax (NVAX) as of Q4 2014, up from 143 in Q3 2014.
- Funds reported $889M of Novavax stock for Q4 2014, up 43% quarter-over-quarter.
- 32 funds opened new Novavax positions in Q4 2014 and 19 closed out, a net change of +13 holders.
- The largest Novavax buyer in Q4 2014 was Invesco, an estimated $5.14M added.
- The largest Novavax seller in Q4 2014 was Camber Capital Management, an estimated $14.4M sold.
Based on aggregated 13F filings for Q4 2014.